[BIC-announce] FW: Killam Lecture - Taking Advantage of the Systemic Immune System to Cure Brain Diseases

[Jennifer Chew, Ms.]

Please discard if this is a duplicate.  Thank you. Jennifer 
 

Jennifer Chew

McConnell Brain Imaging Centre

MNI - WB317

3801 University Street

Montreal, Qc  H3A 2B4

Telephone:  514-398-8554

Fax:  514-398-2975

 

 

________________________________

From: MNISTAFF - Montreal Neurological Institute Staff [mailto:MNISTAFF at LISTS.MCGILL.CA] On Behalf Of Enza Ferracane, Ms.
Sent: Monday, February 15, 2010 9:34 AM
To: MNISTAFF at LISTS.MCGILL.CA
Subject: Killam Lecture



KILLAM LECTURE

 

Speaker:  Serge Rivest, PhD

Professor and Director Department of Molecular Medicine

Université Laval

 

Title:  Taking Advantage of the Systemic Immune System to Cure Brain Diseases

 

Date:  Tuesday, February 16, 2010

 

Place:  de Grandpre Communications Centre

 

Time:  4:00 pm


=============================

Dear colleagues,

Our Killam seminar speaker this week will be Serge Rivest from Laval University. Serge is doing ground-breaking work on the roles of systemic and innate immunity systems in propelling and potentially controlling,  damage result from acute injury (eg. ischemia) and chronic degenerative disease (eg. Alzheimer's disease).  His work is being published in high impact journals (see below) and is having a major impact on the field. 

His seminar, entitled 'Taking advantage of the systemic immune system to cure brain diseases' promises to be enlightening and provocative, will take place at 4 PM on Tuesday February 14 in the de Grandpre Communications Centre at the Montreal Neurological Institute.  I hope to see you there. 

Best regards,
Phil Barker




Some recent Serge Rivest papers:
Rivest S. Regulation of innate immune responses in the brain. Nat Rev Immunol.2009 Jun;9(6):429-39. 

Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R. Regulatory T cells are key cerebroprotective immunomodulators in
acute experimental stroke. Nat Med. 2009 Feb;15(2):192-9. 

Smith DE, Lipsky BP, Russell C, Ketchem RR, Kirchner J, Hensley K, Huang Y, Friedman WJ, Boissonneault V, Plante MM, Rivest S, Sims JE. A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity. 2009 Jun 19;30(6):817-31. 

Richard KL, Filali M, Préfontaine P, Rivest S. Toll-like receptor 2 acts as a  natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci. 2008 May28;28(22):5784-93. 

Gosselin D, Rivest S. MyD88 signaling in brain endothelial cells is essential for the neuronal activity and glucocorticoid release during systemic
inflammation. Mol Psychiatry. 2008 May;13(5):480-97. 

Kang J, Rivest S. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J Cell Biol.
2007 Dec 17;179(6):1219-30. 

Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in  neuropathic pain. J Neurosci. 2007 Nov 7;27(45):12396-406.